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work with its large cadre of molecu-
lar motors is associated with many 




matic  effects  on  their  biochemical 
behaviors. As in the past, a detailed 
understanding of molecular motors 
provides  us  with  insights  into 
how  proteins  in  general  are  able 
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The PML protein induces senescence, and, upon oncogenic stress, its absence promotes 
cellular transformation. In this issue of Cell, Scaglioni et al. (2006) show that phosphoryla-
tion of PML by CK2, a kinase frequently activated in human cancers, promotes PML degra-




led  to  the  discovery  of  the  PML 
gene.  Fusion  between  the  retinoic 
acid  receptor  α  gene  (RARα)  and 
several  other  genes,  most  fre-
quently PML, results in the produc-
tion of chimeric proteins  that drive 





bodies,  the  function  of  which  has 
remained a puzzle to cell biologists. 
Despite  the  fact  that Pml-deficient 
mice exhibit only  subtle defects,  a 
variety of biological functions have 
been  assigned  to  PML,  ranging 
from  senescence  and  apoptosis 
to  combating  viral  infection.  The 
many biochemical processes (such 244  Cell 126, July 28, 2006 ©2006 Elsevas  transcription,  DNA  repair,  and 
proteolysis)  proposed  to  be  under 
PML  control  add  to  the  mystery 
surrounding this protein.
In  this  issue of Cell, Scaglioni et 









and  abrogation  of  sensitivity  to 
CK2 inhibitors. Moreover, in human 
non-small  cell  lung  cancers,  there 
is  an  inverse  relationship  between 




multiple human tumors. This loss of ier Inc.PML  could  promote  tumor  forma-
tion because  the enforced expres-
sion of  activated Ras  (which  leads 
to cancer) induced more aggressive 
lesions in the lungs of Pml-deficient 
mice  compared  to  wild-type  ani-
mals  (Scaglioni  et  al.,  2006).  PML 
is  upregulated  during  senescence 
and  is also  required  for  the  induc-
tion of senescence caused by Ras 
activation  or  PTEN  loss  ex  vivo 
and  in  vivo  (Scaglioni  et  al.,  2006; 
Trotman  et  al.,  2006).  Similarly, 
PML  overexpression  in  primary 
fibroblasts  is  sufficient  to  trigger 
senescence  (Bischof  et  al.,  2002). 
CK2  activation  could  thus  inhibit 
oncogene-induced  senescence  by 
mediating  PML  loss.  Hence,  PML 
transcriptional induction by growth-
suppressive pathways (such as the 
interferon,  p53,  or  TGF-β  signal-
ing pathways) may be balanced by 
PML  protein  degradation  through 
the  activity  of  stress-activated 
kinases  such  as  p38-MAPK  or 
CK2,  resulting  in  modulation  of 
senescence  at  the  early  stages  of 
neoplastic  transformation.  These 




How  does  PML  exert  its  many 
effects  mechanistically?  Several 
models  have  been  proposed.  The 
structural  model  assumes  that  a 
major  function  of  PML  is  to  recruit 
proteins  into  nuclear  bodies.  Con-
centration  of  these  proteins  within 
discrete  nuclear  domains  could 
result  in  their  sequestration,  facili-
tate  interactions,  or  allow  post-
translational modifications to occur. 




tion  interferes with  its ability  to act 
as a transcriptional repressor (Neg-
orev  and Maul,  2001).  Yet,  to  date, 
only  limited  evidence  has  emerged 
demonstrating the impact of protein 





vated  Akt  kinase  together  with  its 
cognate  phosphatase  PP2aC  into 
nuclear  bodies,  thereby  facilitat-
ing  dephosphorylation  of  Akt.  This 
results in removal of activated phos-





of  TGF-β  signaling  appear  to  be 
independent  of  PML  localization  to 
nuclear bodies (Bischof et al., 2002; 
Lin et al., 2004).
A  second  important  area  of 
research  associated  with  PML  is 





its  three  sumoylation  sites  (Wei  et 
al.,  2003;  Zhu  et  al.,  2005).  More-
over, many proteins that accumulate 
in  PML  nuclear  bodies  can  them-
selves  undergo  sumoylation,  and 
their  recruitment  into  PML  nuclear 
bodies  requires  the  same  critical 
sumoylation site in PML. Intriguingly, 
the  CK2  phosphorylation  site  con-
trolling  PML  degradation  identified 
by Scaglioni et al.  (2006)  is  located 
within  a  recently  identified  SUMO-
interacting  motif  (SIM)  (Hecker  et 
al.,  2006),  a  short  sequence  that 
interacts  noncovalently  with  dif-
ferent  SUMO  isoforms.  CK2-medi-
ated  PML  phosphorylation  could 
thus  modulate  the  function  of  this 
domain,  which  may  contribute  to 
the degradation process. A fine dis-
section  of  PML  sumoylation  could 
therefore  bring  important  insights 
into PML function.
The  last  model  is  an  enzymatic 
one.  PML  belongs  to  the  RBCC/
TRIM  family  of  proteins,  many  of 
which are E3 ubiquitin ligases whose 
activities  depend  on  the  integrity 
of  the  RING  finger,  an  important 
motif  in the ligase domain of these 
enzymes  (Meroni  and  Diez-Roux, 
2005). Analysis of a PML RING-fin-
ger mutant in vivo could lend some 
support  to  the  hypothesis  that 
ubiquitin  ligase  activity  is  essen-
tial  for  PML  function.  No  putative 
substrates  of  PML-mediated  ubiq-
uitylation  have  been  identified  to 
date.  Nevertheless,  ubiquitin,  pro-
teasome  components,  and  many 
short-lived  proteins  have  been 
detected  in  PML  nuclear  bodies, 
particularly  after  proteasome  inhi-
bition, arguing for some connection 









niches  specialized  in  posttransla-
tional  modifications  (Meroni  and Cell 126Diez-Roux,  2005).  In  the  case  of 
PML, the RING finger is required for 
the  formation  of  PML  nuclear  bod-
ies,  PML  sumoylation,  and  recruit-
ment  of  proteins,  emphasizing  the 
interdependence between the three 




single  variant  that  triggers  senes-
cence.  Yet  it  was  recently  demon-
strated that the most abundant PML 
species  in  primary  cells  have  not 
been  the  focus of significant atten-
tion (Condemine et al., 2006). Excit-
ing  new developments  are  likely  to 
come  in  this  field,  but  regardless 
of  the  biochemical  mechanism 
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